ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Intermittent Rifampicin on Raltegravir (RIFRAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01424826
Recruitment Status : Completed
First Posted : August 29, 2011
Last Update Posted : October 31, 2013
Sponsor:
Collaborator:
Royal Liverpool and Broadgreen University Hospitals NHS Trust
Information provided by (Responsible Party):
Helen Reynolds, University of Liverpool

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2013
  Actual Study Completion Date : July 2013